Nano-based drug delivery system for therapeutics: a comprehensive review
- PMID: 37549657
- DOI: 10.1088/2057-1976/acedb2
Nano-based drug delivery system for therapeutics: a comprehensive review
Abstract
Nanomedicine and nano-delivery systems hold unlimited potential in the developing sciences, where nanoscale carriers are employed to efficiently deliver therapeutic drugs at specifically targeted sites in a controlled manner, imparting several advantages concerning improved efficacy and minimizing adverse drug reactions. These nano-delivery systems target-oriented delivery of drugs with precision at several site-specific, with mild toxicity, prolonged circulation time, high solubility, and long retention time in the biological system, which circumvent the problems associated with the conventional delivery approach. Recently, nanocarriers such as dendrimers, liposomes, nanotubes, and nanoparticles have been extensively investigated through structural characteristics, size manipulation, and selective diagnosis through disease imaging molecules, which are very effective and introduce a new paradigm shift in drugs. In this review, the use of nanomedicines in drug delivery has been demonstrated in treating various diseases with significant advances and applications in different fields. In addition, this review discusses the current challenges and future directions for research in these promising fields as well.
Keywords: biological system; controlled release; drug delivery system; nanocarriers; nanomedicine.
© 2023 IOP Publishing Ltd.
Similar articles
-
Concepts on Smart Nano-Based Drug Delivery System.Recent Pat Nanotechnol. 2022;16(1):67-89. doi: 10.2174/1872210515666210120113738. Recent Pat Nanotechnol. 2022. PMID: 33494685 Review.
-
Nano based drug delivery systems: recent developments and future prospects.J Nanobiotechnology. 2018 Sep 19;16(1):71. doi: 10.1186/s12951-018-0392-8. J Nanobiotechnology. 2018. PMID: 30231877 Free PMC article. Review.
-
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.Cancer Lett. 2023 Oct 10;574:216397. doi: 10.1016/j.canlet.2023.216397. Epub 2023 Sep 18. Cancer Lett. 2023. PMID: 37730105 Review.
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
CEST MRI trackable nanoparticle drug delivery systems.Biomed Mater. 2021 Feb 18;16(2):024103. doi: 10.1088/1748-605X/abdd70. Biomed Mater. 2021. PMID: 33470986 Free PMC article. Review.
Cited by
-
Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.Biomolecules. 2024 Aug 7;14(8):960. doi: 10.3390/biom14080960. Biomolecules. 2024. PMID: 39199348 Free PMC article. Review.
-
Peptide-Guided Nanoparticle Drug Delivery for Cardiomyocytes.Biology (Basel). 2024 Jan 16;13(1):47. doi: 10.3390/biology13010047. Biology (Basel). 2024. PMID: 38248477 Free PMC article.
-
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.Drug Des Devel Ther. 2024 May 1;18:1469-1495. doi: 10.2147/DDDT.S447496. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38707615 Free PMC article. Review.
-
Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway.Molecules. 2023 Dec 15;28(24):8118. doi: 10.3390/molecules28248118. Molecules. 2023. PMID: 38138606 Free PMC article.
-
Pharmaceutical Applications of Biomass Polymers: Review of Current Research and Perspectives.Polymers (Basel). 2024 Apr 23;16(9):1182. doi: 10.3390/polym16091182. Polymers (Basel). 2024. PMID: 38732651 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
